Preview

Safety and Risk of Pharmacotherapy

Advanced search

Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats

https://doi.org/10.30895/2312-7821-2025-13-2-198-212

Abstract

INTRODUCTION. Frostbite is a common cold injury that is associated with high rates of disability and requires long and difficult treatment. A vascular endothelial growth factor (VEGF)-encoding pCMV-VEGF165 plasmid-based gene therapy product designed for therapeutic angiogenesis may be a promising tool to promote microcirculation recovery and accelerate lesion healing in local cold injury. This hypothesis needs to be tested in an experimental animal study.
AIM. This study aimed to evaluate the efficacy of the pCMV-VEGF165 plasmid gene therapy product for the management of cold injury of a limb in rats.
MATERIALS AND METHODS. The study included 42 mature female outbred white laboratory rats. A third to fourth-degree local cold injury was experimentally induced on the dorsal surface of the left hind paw by applying a neodymium magnet frozen in liquid nitrogen. The animals received periwound injections of the test product (super-coiled circular double-stranded plasmid deoxyribonucleic acid at a dose of 60 μg) and placebo (water for injections) on days 2 and 7 after frostbite modelling. The authors evaluated the general condition of the animals, the condition of the damaged paw, the wound area, the healing rate, the body mass, and, after planned euthanasia, the mass of the hind paws.
RESULTS. Starting from day 7, the rats treated with the test product showed significantly faster tissue regeneration at the site of cold injury than the control animals. The mean wound surface area reduction in the test animals amounted to 47.36% [25.55; 55.45], whereas that in the control animals was 28.95±18.55% (p<0.05). On day 10, the test group still had a significantly higher tissue regeneration rate than the control group (58.70±15.35% vs 42.01±17.41%, respectively, p<0.05). Later, there was no statistically significant difference in the wound surface healing rates between the groups, which could probably be attributed to the nature of wound healing in the experimental model since rodent wounds heal predominantly by contraction.
CONCLUSIONS. The pCMV-VEGF165 plasmid gene therapy product injected in the periwound area at a dose of 60 μg on days 2 and 7 after cold injury simulation in rats reduces damage, accelerates tissue regeneration under the scab, and expedites scarring. 

About the Authors

O. V. Shcheblykina
Belgorod State National Research University
Russian Federation

Olesya V. Shcheblykina, Cand. Sci. (Med.)

85 Pobedy St., Belgorod 308015, Russian Federation



D. A. Kostina
Belgorod State National Research University
Russian Federation

Daria A. Kostina, Cand. Sci. (Med.)

85 Pobedy St., Belgorod 308015, Russian Federation



V. V. Arkhipov
Belgorod State National Research University
Russian Federation

Vladimir V. Arkhipov, Dr. Sci. (Med.), Associate Professor

85 Pobedy St., Belgorod 308015, Russian Federation



E. A. Patrakhanov
Belgorod State National Research University
Russian Federation

Evgeny A. Patrakhanov

85 Pobedy St., Belgorod 308015, Russian Federation



A. A. Dolzhikov
Belgorod State National Research University
Russian Federation

Aleksandr A. Dolzhikov, Dr. Sci. (Med.), Professor

85 Pobedy St., Belgorod 308015, Russian Federation



V. V. Gureev
Belgorod State National Research University
Russian Federation

Vladimir V. Gureev, Dr. Sci. (Med.), Professor

85 Pobedy St., Belgorod 308015, Russian Federation



N. I. Zhernakova
Belgorod State National Research University
Russian Federation

Nina I. Zhernakova, Dr. Sci. (Med.), Professor

85 Pobedy St., Belgorod 308015, Russian Federation



O. A. Osipova
Belgorod State National Research University
Russian Federation

Olga A. Osipova, Dr. Sci. (Med.), Professor 

85 Pobedy St., Belgorod 308015, Russian Federation



M. V. Pokrovskii
Belgorod State National Research University
Russian Federation

Mikhail V. Pokrovskii, Dr. Sci. (Med.), Professor

85 Pobedy St., Belgorod 308015, Russian Federation



References

1. Rodway GW, Cochran A, Giesbrecht GG, McDevitt M, Imray CH, Johnson EL et al. Wilderness Medical Society Clinical practice guidelines for the prevention and treatment of frostbite: 2019 update. Wilderness Environ Med. 2019;30(4S):S19–S32. https://doi.org/10.1016/j.wem.2019.05.002

2. Murphy JV, Banwell PE, Roberts AH, McGrouther DA. Frostbite: Pathogenesis and treatment. J Trauma. 2000;48(1):171–8. https://doi.org/10.1097/00005373-200001000-00036

3. Mikhailichenko MI, Figurskiy SA, Mudrov VA, Dorzheev VV, Mikhaili­chenko YuV, Shapovalov KG. Rhabdomyolysis in the pathogenesis of local cold injury. Thrombosis, Hemostasis and Rheology. 2023;4:68–74 (In Russ.). https://doi.org/10.25555/THR.2023.4.1079

4. Shcheblykin DV, Bolgov AA, Pokrovskii MV, Stepenko JV, Tsuverkalova JM, Shcheblykina OV, et al. Endothelial dysfunction: Developmental mechanisms and therapeutic strategies. Research Results in Pharmacology. 2022;8(4):115–39. https://doi.org/10.3897/rrpharmacology.8.80376

5. Wang W, Liu P, Zhu W, Li T, Wang Y, Wang Y, et al. Skin organoid transplantation promotes tissue repair with scarless in frostbite. Protein Cell. 2024;4:pwae055. https://doi.org/10.1093/procel/pwae055

6. Ishchenko RV, Fistal EYa, Filimonov DA, Pokrovskii MV, Arkhipov VV, Nalyotov SV, Arefiev VV, Makienko VV, Nalyotova EN. Off-label use of Neovasculgen for II–III degree foot frostbite: A case report. Safety and Risk of Pharmacotherapy. 2024;12(4):409–19 (In Russ.). https://doi.org/10.30895/2312-7821-2024-429

7. Aizawa T, Kuwabara M, Kubo S, Aoki S, Azuma R, Kiyosawa T. Protective effect of extract of Ginkgo biloba 761 against frostbite injury in rats. Plast Reconstr Surg. 2019;143(6):1657–64. https://doi.org/10.1097/PRS.0000000000005648

8. Handford C, Buxton P, Russell K, Imray CE, McIntosh SE, Freer L, et al. Frostbite: A practical approach to hospital management. Extrem Physiol Med. 2014;3(1):7. https://doi.org/10.1186/2046-7648-3-7

9. DeGroot DW, Castellani JW, Williams JO, Amoroso PJ. Epidemiology of U.S. Army cold weather injuries, 1980-1999. Aviat Space Environ Med. 2003;74(5):564–70. PMID: 12751587

10. Esina DD, Filippova EB, Murgaeva NV. On the differences in thermoregulation in individuals of different sexes. Bulletin of the Russian Military Medical Academy. 2022;41(S2):154–6 (In Russ.). EDN: NVIBZP

11. Bankhead P, Loughrey MB. Fernández JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: Open source software for digital pathology image analysis. Scientific Reports. 2017;7:16878. https://doi.org/10.1038/s41598-017-17204-5

12. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Reviews. 1997;18(1):4–25. https://doi.org/10.1210/edrv.18.1.0287

13. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition. Cellular Signalling. 2007;19(10):2003–12. https://doi.org/10.1016/j.cellsig.2007.05.013

14. Klabukov I, Balyasin M, Krasilnikova O, Tenchurin T, Titov A, Krasheninnikov M, et al. Angiogenic modification of microfibrous polycaprolactone by pCMV-VEGF165 plasmid promotes local vascular growth after implantation in rats. Int J Mol Sci. 2023;24(2):1399. https://doi.org/10.3390/ijms24021399.

15. Eremin PS, Deev RV, Bozo IYa, Deshevoi YuB, Lebedev VG, Eremin II, et al. Tissue healing after severe cutaneous local radiation injuries under gene-mediated induction of angiogenesis using “Neovasculgen”. Journal of Anatomy and Histopathology. 2020;9(2):26–34 (In Russ.). https://doi.org/10.18499/2225-7357-2020-9-2-26-34

16. Chervyakov YuV, Staroverov IN, Moskovskiy IA, Lonchakova OM, Istomin AV. Ten-year results of conservative treatment of patients with infrainguinal occlusive disease using VEGF165 plasmid construct. Russian Journal of Cardiology and Cardiovascular Surgery. 2023;16(1):110–7 (In Russ.). https://doi.org/10.17116/kardio202316011110

17. Davidson JM. Animal models for wound repair. Arch Dermatol Res. 1998;290(Suppl):S1–11. https://doi.org/10.1007/pl00007448

18. Greenhalgh DG. Models of wound healing. J Burn Care Rehabil. 2005;26:293–305. https://doi.org/10.1097/01.bcr.0000169885.66639.b5

19. Liskutin T, Batey J, Li R, Schweigert C, Mestril R. Increased heat shock protein expression decreases inflammation in skeletal muscle during and after frostbite injury. Curr Mol Med. 2020;20(9):733–40. https://doi.org/10.2174/1566524020666200407083131

20. Mikhailichenko MM, Shapovalov KG, Mudrov VA, Mikhaylichenko SI, Mikhaylichenko AV, Hanina YuS, Mikhailichenko YuV. Prerenal kidney damage in patients with local cold injury. Acta Biomedica Scientifica. 2022;7(4):62–70 (In Russ.). https://doi.org/10.29413/ABS.2022-7.4.7

21. Myles WS, Brown TE. Serum creatine phosphokinase levels in rats following cold injury. International Journal of Biometeorology. 1973;17(2):177–84. https://doi.org/10.1007/bf01809805


Supplementary files

1. Figure 1, tables 2–5
Subject
Type Исследовательские инструменты
Download (249KB)    
Indexing metadata ▾

Review

For citations:


Shcheblykina O.V., Kostina D.A., Arkhipov V.V., Patrakhanov E.A., Dolzhikov A.A., Gureev V.V., Zhernakova N.I., Osipova O.A., Pokrovskii M.V. Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats. Safety and Risk of Pharmacotherapy. 2025;13(2):198-212. (In Russ.) https://doi.org/10.30895/2312-7821-2025-13-2-198-212

Views: 122


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2312-7821 (Print)
ISSN 2619-1164 (Online)